Atrium Therapeutics, Inc. (RNA)

Last Closing Price: 11.35 (2026-07-31)

Expense Ratio (Quarterly)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

Atrium Therapeutics, Inc. (RNA) Expense Ratio data is not available.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
19.64M
-16.63M
--
19.64M
36.91M
-17.28M
0.65M
-16.63M
-16.63M
-16.63M
-16.63M
-16.63M
-16.63M
-17.28M
-17.13M
17.11M
17.11M
-0.97
-0.97
Balance Sheet Financials
285.56M
4.34M
6.79M
292.36M
21.91M
--
36.35M
58.26M
234.10M
234.10M
234.10M
17.11M
Cash Flow Statement Financials
-31.14M
-2.10M
301.50M
--
268.26M
268.26M
12.21M
--
--
Fundamental Metrics & Ratios
13.04
--
--
--
--
100.00%
-88.01%
-88.01%
--
-84.71%
-84.71%
-33.24M
--
Expense Ratio
--
--
0.07
--
1.31
68.75
-7.11%
-7.11%
-5.69%
-7.11%
13.69
-1.94
-1.82